27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
According to the analysts, the company's Q2 results demonstrated sequential stabilization of the company's core vascular intervention businesses for peripheral and coronary intervention, clearing the way for the company's Stellarex drug-coated balloon (DCB) platform to take over as the central value driver for the stock.
"By our analysis, >50 percent of our projected 12-month target valuation is now driven by the long-term growth and value associated with Stellarex," UBS said.
At time of writing, Spectranetics was up 4.28 percent on the day at $24.08.
Full ratings data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.